Hepatic regulation of apolipoprotein B.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques.NPJ cardiovascular health · 2026
   Review
2. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.Metabolites · 2021
   Review
3. Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine model.BioMed research international · 2015
   Article
4. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Journal of biomedical research · 2014
   Article
5. Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.Journal of the American Heart Association · 2012
   Article
6. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.Journal of lipid research · 2009
   Review
7. Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice.Toxicology and applied pharmacology · 2008
   Article
8. FoxO1 integrates insulin signaling to VLDL production.Cell cycle (Georgetown, Tex.) · 2008
   Review
9. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.The Journal of clinical investigation · 2008
   Article
10. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus.PLoS pathogens · 2007
    Review
11. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as